ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ALTO vs GEVO // EV/EBITDA & P/E VALUATION

Alto Ingredients Inc. (NASDAQ) VS. Gevo Inc. (NASDAQ) • 15-METRIC TALLY: ALTO 7 — GEVO 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALTO VS. GEVO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ALTO GEVO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 3.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 2.00% -2.90% +4.90 ALTO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 28.6x — — TIE /valuation <GO>
Free Cash Flow Yield 3.05% -14.55% +17.60 ALTO /fcf-yield <GO>
Operating Margin 0.80% -12.60% +13.40 ALTO /operating-margins <GO>
Net Profit Margin 0.00% -21.10% +21.10 ALTO /net-margins <GO>
Revenue Growth (YoY) -4.90% 180.00% -184.90 GEVO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.98 0.20 +0.78 ALTO /balance-sheet <GO>
Piotroski F-Score Quality 7/9 5/9 +2.00 ALTO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.7 43.6 +2.10 ALTO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $283.1M $299.2M -$16.0M GEVO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ALTO REV GEVO REV ALTO GROSS % GEVO GROSS % ALTO FCF GEVO FCF
FY 2025 $917.9M $160.6M 3.8% — $8.6M -$43.5M
FY 2024 $965.3M $16.9M 1.0% — -$14.6M -$108.5M
FY 2023 $1.22B $17.2M — — $22.0M -$53.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALTO // BETA —
GEVO // BETA —